DE69831427D1 - Benzo(c)quinolizinderivative und deren verwendung als 5 alpha-reduktase-hemmer - Google Patents

Benzo(c)quinolizinderivative und deren verwendung als 5 alpha-reduktase-hemmer

Info

Publication number
DE69831427D1
DE69831427D1 DE69831427T DE69831427T DE69831427D1 DE 69831427 D1 DE69831427 D1 DE 69831427D1 DE 69831427 T DE69831427 T DE 69831427T DE 69831427 T DE69831427 T DE 69831427T DE 69831427 D1 DE69831427 D1 DE 69831427D1
Authority
DE
Germany
Prior art keywords
benzo
reductase inhibitors
quinoline derivatives
alpha reductase
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69831427T
Other languages
English (en)
Other versions
DE69831427T2 (de
Inventor
Antonio Guarna
Mario Serio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Serono SA
Original Assignee
Applied Research Systems ARS Holding NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems ARS Holding NV filed Critical Applied Research Systems ARS Holding NV
Publication of DE69831427D1 publication Critical patent/DE69831427D1/de
Application granted granted Critical
Publication of DE69831427T2 publication Critical patent/DE69831427T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE69831427T 1997-12-23 1998-12-21 Benzo(c)quinolizinderivative und deren verwendung als 5 alpha-reduktase-hemmer Expired - Fee Related DE69831427T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97122733A EP0926148A1 (de) 1997-12-23 1997-12-23 Benzo (c)quinolizine-derivate,deren herstellung und verwendung als 5-alpha-reduktase-hemmer
EP97122733 1997-12-23
PCT/EP1998/008582 WO1999033828A1 (en) 1997-12-23 1998-12-21 Benzo[c]quinolizine derivatives and their use as 5 alpha-reductases inhibitors

Publications (2)

Publication Number Publication Date
DE69831427D1 true DE69831427D1 (de) 2005-10-06
DE69831427T2 DE69831427T2 (de) 2006-06-08

Family

ID=8227866

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69831427T Expired - Fee Related DE69831427T2 (de) 1997-12-23 1998-12-21 Benzo(c)quinolizinderivative und deren verwendung als 5 alpha-reduktase-hemmer

Country Status (22)

Country Link
US (1) US6962925B1 (de)
EP (2) EP0926148A1 (de)
JP (1) JP2001527074A (de)
KR (1) KR100580742B1 (de)
CN (1) CN1144804C (de)
AR (1) AR017964A1 (de)
AT (1) ATE303382T1 (de)
AU (1) AU744105B2 (de)
BR (1) BR9813836A (de)
CA (1) CA2315055A1 (de)
DE (1) DE69831427T2 (de)
EA (1) EA002831B1 (de)
EE (1) EE04615B1 (de)
ES (1) ES2245053T3 (de)
HK (1) HK1033128A1 (de)
IL (1) IL136919A0 (de)
NO (1) NO326034B1 (de)
PT (1) PT1066284E (de)
SI (1) SI1066284T1 (de)
UA (1) UA66371C2 (de)
WO (1) WO1999033828A1 (de)
ZA (1) ZA9811762B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0926148A1 (de) * 1997-12-23 1999-06-30 Applied Research Systems Ars Holding N.V. Benzo (c)quinolizine-derivate,deren herstellung und verwendung als 5-alpha-reduktase-hemmer
WO2000006167A1 (en) * 1998-07-29 2000-02-10 Merk & Co., Inc. Tricyclic compounds
KR100785088B1 (ko) 2006-05-23 2007-12-12 한국과학기술연구원 두 개의 엑소 메틸렌을 가지는 고리가 접합된 락탐화합물과이의 제조방법
AU2007273441A1 (en) * 2006-07-13 2008-01-17 Nihon Nohyaku Co., Ltd. Parasitic plant control agent and use thereof
GB201506894D0 (en) * 2015-04-23 2015-06-10 Galapagos Nv Novel dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
CN106008423B (zh) * 2016-06-24 2018-02-02 云南民族大学 一种苯丙素类化合物及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5239075A (en) * 1991-08-21 1993-08-24 Eli Lilly And Company Process for the preparation of benzo (f) quinolinones
ES2169026T3 (es) * 1991-08-21 2002-07-01 Lilly Co Eli Benzo(f)quinolinonas como inhibidores de 5-alfa-reductasa.
EP0591582B1 (de) * 1991-08-21 1999-01-20 Eli Lilly And Company Hexahydrobenzo(f)quinolinone als 5-Alpha-reduktase Inhibitoren
US5250539A (en) * 1991-08-21 1993-10-05 Eli Lilly And Company Hexahydrobenzo[f]quinolinones
AU6413594A (en) * 1993-03-24 1994-10-11 Merck & Co., Inc. Substituted 3-phenanthridinone derivatives as 5alpha-reductase inhibitors
US5578724A (en) * 1994-09-20 1996-11-26 Eli Lilly And Company Process for preparation of benzo[f]quinolinones
IT1286545B1 (it) * 1996-02-09 1998-07-15 Antonio Guarna Derivati benzo(c) chinolizinici,loro preparazione ed uso come inibitori delle 5-alfa-riduttasi
ITFI970193A1 (it) * 1997-08-01 1999-02-01 Applied Research Systems Uso di derivati benzo(c) chinolizinici come regolatori della crescita delle piante e composizioni ad uso agricolo che contengono tali
EP0926148A1 (de) * 1997-12-23 1999-06-30 Applied Research Systems Ars Holding N.V. Benzo (c)quinolizine-derivate,deren herstellung und verwendung als 5-alpha-reduktase-hemmer

Also Published As

Publication number Publication date
KR100580742B1 (ko) 2006-05-15
ZA9811762B (en) 1999-06-23
AU744105B2 (en) 2002-02-14
CN1284954A (zh) 2001-02-21
CN1144804C (zh) 2004-04-07
EP1066284A1 (de) 2001-01-10
EE04615B1 (et) 2006-04-17
NO326034B1 (no) 2008-09-01
AU2419499A (en) 1999-07-19
DE69831427T2 (de) 2006-06-08
SI1066284T1 (sl) 2005-12-31
EP0926148A1 (de) 1999-06-30
HK1033128A1 (en) 2001-08-17
AR017964A1 (es) 2001-10-24
WO1999033828A1 (en) 1999-07-08
EA002831B1 (ru) 2002-10-31
EP1066284B1 (de) 2005-08-31
ATE303382T1 (de) 2005-09-15
BR9813836A (pt) 2000-10-10
KR20010033432A (ko) 2001-04-25
CA2315055A1 (en) 1999-07-08
PT1066284E (pt) 2005-11-30
UA66371C2 (en) 2004-05-17
IL136919A0 (en) 2001-06-14
ES2245053T3 (es) 2005-12-16
EE200000387A (et) 2001-12-17
EA200000697A1 (ru) 2000-12-25
US6962925B1 (en) 2005-11-08
NO20003199L (no) 2000-08-23
NO20003199D0 (no) 2000-06-20
JP2001527074A (ja) 2001-12-25

Similar Documents

Publication Publication Date Title
DE59913617D1 (de) Indolderivate und deren Verwendung als Inhibitoren der Phosphodiesterase 4.
DE69826662D1 (de) 4-brom or 4-iod-phenylamino-benzhydroxamsäurederivate und ihre anwendung als mek-inhibitoren
DE69636801D1 (de) Dioxinoderivate und ihre Verwendung als Dopamine Agonisten
DE69836346D1 (de) Heteroaryl aminoguanidin- und alkoxyguanidinderivate und ihre verwendung als proteasehemmer
DE59908600D1 (de) Substituierte benzimidazole und ihre verwendung als parp inhibitoren
DE69926800D1 (de) Benzoheterozyklen und ihre verwendung als mek inhibitoren
DE60036803D1 (de) Arylmethyl-carbonylamino-thiazolderivate und ihre verwendung als antitumormittel
DE69836378D1 (de) 2-(4-brom or 4-iod phenylamino)benzoesäurederivate und ihre anwendung als mek-inhibitoren
ATE202347T1 (de) Aminothiophencarbonsäureamide und ihre verwendung als phosphodiesterase inhibitoren
DE69332898D1 (de) 4-Carboxamidopiperidinderivate und ihre Verwendung als Neurokinin Antagonisten
ATE250035T1 (de) Chinolin- und chinazolin-derivate als crf antagonisten
DE60015089D1 (de) 3-phenylpyridinderivative und deren verwendung als nk-1 rezeptorantagonisten
DE69610316D1 (de) Piperazin-derivate und ihre verwendung als 5-ht1a-antagoniste
DE69717647D1 (de) 3-mercaptoacetylamino-1,5-substituierte-2-oxo-azepan derivate und deren verwendung als inhibitoren von matrix-metalloproteinasen
DE69510228D1 (de) Piperidinessigsäurederivate und ihre verwendung als fibrinogenantagonistmittel
DE69613805T2 (de) Diiminoquinonderivate und ihre Verwendung als Elektronübertragungsmittel
DE69703437T2 (de) 2-(3h)-oxazolone-derivate und ihre verwendung als cox-2 inhibitoren
ATE253059T1 (de) Substituierte 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2- one und ihre verwendung als lipase-hemmer
DE69708629T2 (de) Alkyloxyamin-substituierte fluorenonderivate und ihre verwendung als proteinkinase-c-inhibitoren
DE69831427D1 (de) Benzo(c)quinolizinderivative und deren verwendung als 5 alpha-reduktase-hemmer
DE69832902D1 (de) Oromukosal-zytokin-zusammensetzungen und ihre verwendung
DE69717463T2 (de) hCG UND DERIVATE ALS MATRIXMETALLOPROTEASE-INHIBITOREN
DE60008539D1 (de) Substituierte isochinolinderivate und ihre verwendung als anticonvulsiva
DE69809829T2 (de) Untergrunderkennung und Kompensation
DE69607578D1 (de) Diiminoquinonderivate und ihre Verwendung als Elektronübertragungsmittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: LABORATOIRES SERONO S.A., COINSINS, VAUD, CH

8339 Ceased/non-payment of the annual fee